Uncategorized

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

November 21, 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

November 20, 2024

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

November 13, 2024

THIS WEEK'S STORIES

Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors

November 19, 2024

Kevin Krause named President and CEO of ArrePath

November 19, 2024

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

November 15, 2024

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

LEO Pharma initiates head-to-head study to evaluate brodalumab vs. guselkumab in adult patients with moderate-to-severe psoriasis who have inadequate response to ustekinumab

Sigma Analytical Partners with Ecolab to Help Ensure Safe Production of Cannabis Products

Most Read

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

Bayer Announces ‘Project Enhanced S3’ to Enable Companies to Realize Additional Sustainability Value from Carbon Removal Projects

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

EDITOR PICKS

Vertex Pharmaceuticals CEO Reshma Kewalramani Honored with the Lifetime Achievement Award 2024

Accelerating Climate Action, 11 Boston and Cambridge Institutions Collaborate to Invest in Wind and Solar Power

Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer

THIS WEEK'S STORIES

Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors

Kevin Krause named President and CEO of ArrePath

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B

POPULAR CATEGORY

ABOUT US

FOLLOW US

Uncategorized

No posts to display

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US